Genetic Convergence of Parkinson’s Disease and Lysosomal Storage Disorders

被引:0
作者
Hao Deng
Xiaofei Xiu
Joseph Jankovic
机构
[1] The Third Xiangya Hospital,Center for Experimental Medicine
[2] Central South University,Department of Neurology
[3] The Third Xiangya Hospital,Department of Neurology
[4] Central South University,undefined
[5] Baylor College of Medicine,undefined
来源
Molecular Neurobiology | 2015年 / 51卷
关键词
Parkinson’s disease; Lysosomal storage disorder; Genetics; Gaucher disease; Niemann-Pick disease;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease is a common progressive neurodegenerative disorder characterized by predominant degeneration of the dopaminergic neurons in the substantia nigra pars compacta and the presence of intracellular inclusions enriched in α-synuclein, resulting in a variety motor and nonmotor symptoms. Lysosomal storage disorders are a group of disorders including Gaucher disease, Niemann-Pick disease, and neuronal ceroid lipofuscinoses caused by the defective activity of lysosomal and nonlysosomal proteins. In addition to an overlap in some clinical features between lysosomal storage disorders and Parkinson’s disease, the two disorders may be also linked pathogenically. There is growing support for the notion that mutations in genes causing lysosomal storage disorders including the glucocerebrosidase gene, the sphingomyelin phosphodiesterase 1 gene, and the NPC1 gene may increase risk for developing Parkinson’s disease. In this review, we discuss the recent advances in the genetic convergence of Parkinson’s disease and lysosomal storage disorders, shedding new light on the understanding of shared pathogenic pathways.
引用
收藏
页码:1554 / 1568
页数:14
相关论文
共 1393 条
[1]  
Jankovic J(2011)Diagnosis and treatment of psychogenic parkinsonism J Neurol Neurosurg Psychiatry 82 1300-1303
[2]  
Deng H(2013)The Mov Disord 28 569-575
[3]  
Gao K(2011) gene and Parkinson’s disease Curr Pharm Des 17 2558-2574
[4]  
Jankovic J(2011)Gene therapy for lysosomal storage diseases: progress, challenges and future prospects Expert Opin Biol Ther 11 1153-1167
[5]  
Seregin SS(2014)Gene therapy for lysosomal storage disorders Nature 510 68-75
[6]  
Amalfitano A(2014)Sphingolipid lysosomal storage disorders Brain 137 1304-1322
[7]  
Gritti A(2004)Glucocerebrosidase is shaking up the synucleinopathies Nat Rev Mol Cell Biol 5 554-565
[8]  
Platt FM(2010)The cell biology of lysosomal storage disorders J Biol Chem 285 20423-20427
[9]  
Siebert M(2012)Common and uncommon pathogenic cascades in lysosomal storage diseases Lancet Neurol 11 986-998
[10]  
Sidransky E(2004)The link between the GBA gene and parkinsonism Mol Genet Metab 82 192-207